Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M Bénéteau
Glycolysis Inhibition Targets McL-1 to Restore Sensitivity of Lymphoma Cells to ABT-737-induced Apoptosis
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Related publications
ABT-737 Induces Apoptosis in Mantle Cell Lymphoma Cells With a BCL-2high/McL-1low Profile and Synergizes With Other Antineoplastic Agents
Clinical Cancer Research
Cancer Research
Oncology
Nucleoside Analog ARC Targets McL-1 to Induce Apoptosis in Leukemia Cells
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Inhibition of MEK/ERK1/2 Sensitizes Lymphoma Cells to Sorafenib-Induced Apoptosis
Leukemia Research
Cancer Research
Oncology
Hematology
Cap-Translation Inhibitor, 4egi-1, Restores Sensitivity to ABT-737 Apoptosis Through Cap-Dependent and -Independent Mechanisms in Chronic Lymphocytic Leukemia
Clinical Cancer Research
Cancer Research
Oncology
Ouabain Downregulates McL-1 and Sensitizes Lung Cancer Cells to TRAIL-induced Apoptosis
American Journal of Physiology - Cell Physiology
Physiology
Cell Biology
Chemotherapeutic Drugs Sensitize Human Renal Cell Carcinoma Cells to ABT-737 by a Mechanism Involving the Noxa-Dependent Inactivation of McL-1 or A1
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
McL-1 Down-Regulation Potentiates ABT-737 Lethality by Cooperatively Inducing Bak Activation and Bax Translocation
Cancer Research
Cancer Research
Oncology
Chronic Lymphocytic Leukemia Requires BCL2 to Sequester Prodeath BIM, Explaining Sensitivity to BCL2 Antagonist ABT-737
Journal of Clinical Investigation
Medicine
Synergistic BCL-2 Inhibition by ABT-737 and Cyclosporine A
Apoptosis : an international journal on programmed cell death
Cell Biology
Pharmacology
Biochemistry
Clinical Biochemistry
Cancer Research
Pharmaceutical Science
